{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:02:20Z","timestamp":1787868140032,"version":"build-2784847793"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1307500"],"award-info":[{"award-number":["2017YFC1307500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1307504"],"award-info":[{"award-number":["2017YFC1307504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925031"],"award-info":[{"award-number":["81925031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108026"],"award-info":[{"award-number":["81820108026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003389"],"award-info":[{"award-number":["82003389"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801229"],"award-info":[{"award-number":["81801229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cerebral small vessel disease (CSVD) is common among older people and it could lead to dementia. Whether anti-platelet therapy (APT) could retard the cognitive decline of CSVD is unclear. The aim of the study was to evaluate, in newly diagnosed CSVD patients without dementia, the association between the APT and dementia during follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a nested case-control study within a CSVD cohort. Dementia cases, such as vascular dementia (VaD), Alzheimer\u2019s disease (AD), and unspecified dementia (UD), were individually matched (1:1) to controls by age, sex, and follow-up time. Conditional logistic regression models were used to estimate the odds ratios (<jats:italic>OR<\/jats:italic>s) between APT and dementia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 9,991 patients in a cohort screened from January 2009 to December 2019 and followed-up until November 2020, 131 dementia cases were finally included and successfully matched to 131 controls. Among 262 patients with CSVD, the mean [standard deviation (SD)] age was 73.9 (7.9) years and 126 (48.1%) were men. The median [interquartile range (IQR)] follow-up periods were 4.73 (2.70\u20136.57) years in the control group and 2.94 (1.34\u20134.89) years in the case group. According to MRI at baseline, the case group showed higher CSVD burden in lacune(s) (<jats:italic>p<\/jats:italic> = 0.001), moderate-to-severe white matter hyperintensities (WMHs) (<jats:italic>p<\/jats:italic> = 0.015), enlarged perivascular spaces (EPVSs) in basal ganglia (<jats:italic>p<\/jats:italic> = 0.005), and brain atrophy (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The APT was associated with the lower overall dementia risk and the matched <jats:italic>OR<\/jats:italic> was statistically significant (a<jats:italic>OR<\/jats:italic> 0.15, 95% <jats:italic>CI<\/jats:italic> 0.05\u20130.45, <jats:italic>p<\/jats:italic> = 0.001), and clopidogrel showed protective effects on overall dementia (a<jats:italic>OR<\/jats:italic> 0.30, 95% <jats:italic>CI<\/jats:italic> 0.14\u20130.62, <jats:italic>p<\/jats:italic> = 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Among newly diagnosed CSVD patients without dementia, APT was associated with a lower risk of dementia and clopidogrel might be an appropriate candidate in preventing dementia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.788407","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:59:20Z","timestamp":1648706360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-platelet Therapy Is Associated With Lower Risk of Dementia in Patients With Cerebral Small Vessel Disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Dong","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongteng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/ijs.12466","article-title":"Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions.","volume":"10","author":"Bath","year":"2015","journal-title":"Int. J. Stroke"},{"key":"B2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s1474-4422(07)70293-4","article-title":"Aspirin in Alzheimer\u2019s disease (AD2000): a randomised open-label trial.","volume":"7","author":"Bentham","year":"2008","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.jalz.2018.04.007","article-title":"Cerebral small vessel disease and the risk of dementia: a systematic review and meta-analysis of population-based evidence.","volume":"14","author":"Bos","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","article-title":"CNS small vessel disease: a clinical review.","volume":"92","author":"Cannistraro","year":"2019","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000091981","article-title":"Vascular dementia: potential of antiplatelet agents in prevention.","volume":"55","author":"Chabriat","year":"2006","journal-title":"Eur. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.5853\/jos.2017.02922","article-title":"Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies.","volume":"20","author":"Cuadrado-Godia","year":"2018","journal-title":"J. Stroke"},{"key":"B7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10245330310001621260","article-title":"Clopidogrel: interactions with the P2Y12 receptor and clinical relevance.","volume":"8","author":"Dorsam","year":"2003","journal-title":"Hematology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1006\/pmed.1994.1093","article-title":"Nested case-control studies.","volume":"23","author":"Ernster","year":"1994","journal-title":"Prev. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging.","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am. J. Roentgenol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1017\/s104161020500164x","article-title":"Progress of leukoaraiosis is inhibited by correction of platelet hyper-aggregability.","volume":"17","author":"Fujita","year":"2005","journal-title":"Int. Psychogeriatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","article-title":"Secondary stroke prevention.","volume":"13","author":"Hankey","year":"2014","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"B13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2477","article-title":"Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS, (leukoaraiosis and disability) study cohort.","volume":"339","author":"Inzitari","year":"2009","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006378.pub2","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease.","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39166.597836.BE","article-title":"Low dose aspirin and cognitive function in the women\u2019s health study cognitive cohort.","volume":"334","author":"Kang","year":"2007","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00057","article-title":"Unconditional or conditional logistic regression model for age-matched case-control data?","volume":"6","author":"Kuo","year":"2018","journal-title":"Front. Public Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/STROKEAHA.114.008422","article-title":"Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.","volume":"46","author":"Kwok","year":"2015","journal-title":"Stroke"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03137-x","article-title":"Age-related cerebral small vessel disease and inflammaging.","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1073\/pnas.1520398113","article-title":"Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.","volume":"113","author":"Lou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1161\/strokeaha.113.003128","article-title":"Systematic review and meta-analysis of interventions tested in animal models of lacunar stroke.","volume":"45","author":"Pedder","year":"2014","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/ijs.12054","article-title":"Enlarged perivascular spaces and cerebral small vessel disease.","volume":"10","author":"Potter","year":"2015","journal-title":"Int. J. Stroke"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1212\/wnl.0000000000009277","article-title":"Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.","volume":"95","author":"Ryan","year":"2020","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1161\/strokeaha.112.662593","article-title":"White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.","volume":"43","author":"Schmidt","year":"2012","journal-title":"Stroke"},{"key":"B26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2007-996108","article-title":"Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.","volume":"23","author":"Schr\u00f6r","year":"1997","journal-title":"Semin. Thromb. Hemost."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1046\/j.1463-1326.2002.0040s2s14.x","article-title":"The pharmacology of cilostazol.","author":"Schr\u00f6r","year":"2002","journal-title":"Diabetes Obes. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0140-6736(02)07605-5","article-title":"Case-control studies: research in reverse.","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/svn-2016-000035","article-title":"Update on cerebral small vessel disease: a dynamic whole-brain disease.","volume":"1","author":"Shi","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs.","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med. Res. Methodol."},{"key":"B31","first-page":"V19","article-title":"Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.","volume":"62","author":"Smith","year":"1980","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","article-title":"Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations.","volume":"15","author":"Thrippleton","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline.","volume":"348","author":"Vermeer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa070972","article-title":"Incidental findings on brain MRI in the general population.","volume":"357","author":"Vernooij","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(07)61602-x","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology, (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet (London, England)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/s1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1007\/s12035-018-1374-4","article-title":"PDE3 Inhibitors Repurposed as treatments for age-related cognitive impairment.","volume":"56","author":"Yanai","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/strokeaha.118.022485","article-title":"Practical small vessel disease score relates to stroke, dementia, and death.","volume":"49","author":"Yilmaz","year":"2018","journal-title":"Stroke"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.788407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:59:25Z","timestamp":1648706365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.788407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":38,"alternative-id":["10.3389\/fnagi.2022.788407"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.788407","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"788407"}}